AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15284540 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (historical nonintubated controls).
Number of subjects: 426
Study 15284540 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital ETCO2/Spo2 monitoring during paramedic rapid sequence intubation (RSI).
Number of subjects: 426
Study 15284540 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital ETCO2/Spo2 monitoring during paramedic RSI.
Number of subjects: 426
Study 11300330 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline-based first-line chemotherapy
Number of subjects: 1430
Study 10224737 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral choice treatment (BCT)
Number of subjects: 24
Study 10224737 — intervention group
Group type: COMPARATOR
Intervention: Traditional behavioral treatment (TBT)
Number of subjects: 24
Study 10224737 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 1839490 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin (6 mg/kg q24h i.v. after initial loading at 6 mg/kg q12h for three doses)
Number of subjects: 50
Study 1839490 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin (15 mg/kg q12h i.v.)
Number of subjects: 50
Study 1839490 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 50
Study 1839490 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 50
Study 1839490 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin and cyclosporin A
Number of subjects: 50
Study 1839490 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin and cyclosporin A
Number of subjects: 50
Study 1839490 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin and amphotericin B
Number of subjects: 50
Study 1839490 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin and amphotericin B
Number of subjects: 50
Study 6476854 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA-UV-B therapy administered twice weekly
Number of subjects: 21
Study 6476854 — intervention group
Group type: COMPARATOR
Intervention: Lower doses of PUVA and UV-B
Number of subjects: 21
Study 31051059 — intervention group
Group type: EXPERIMENTAL
Intervention: HBO2 therapy
Number of subjects: 115
Study 31051059 — intervention group
Group type: COMPARATOR
Intervention: Control (no HBO2 therapy)
Number of subjects: 115
Study 29314138 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower insulin dosages
Number of subjects: 187
Study 29314138 — intervention group
Group type: COMPARATOR
Intervention: Irregular menses
Number of subjects: 187
Study 29314138 — intervention group
Group type: COMPARATOR
Intervention: Diabetes-specific variables
Number of subjects: 187
Study 26965763 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid fortified milk (FM) providing 400 μg folic acid per day
Number of subjects: 70
Study 26965763 — intervention group
Group type: COMPARATOR
Intervention: Unfortified placebo milk (PM)
Number of subjects: 70
Study 23681403 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard adjuvant chemotherapy (cyclophosphamide-methotrexate-5-fluorouracil or doxorubicin-cyclophosphamide)
Number of subjects: 297
Study 23681403 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 297
Study 23681403 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 297
Study 21285003 — intervention group
Group type: EXPERIMENTAL
Intervention: Accessory mobilisation technique
Number of subjects: 13
Study 21285003 — intervention group
Group type: COMPARATOR
Intervention: Manual contact control
Number of subjects: 13
Study 21285003 — intervention group
Group type: COMPARATOR
Intervention: No contact control
Number of subjects: 13
Study 19835125 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhongzhu (TE 3) group
Number of subjects: 42
Study 19835125 — intervention group
Group type: EXPERIMENTAL
Intervention: Yanglingquan (GB 34) group
Number of subjects: 42
Study 17454341 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg
Number of subjects: 62
Study 17454341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 15480981 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice a day plus omeprazole placebo once daily
Number of subjects: 287
Study 15480981 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 75 mg twice daily plus omeprazole 20 mg once daily
Number of subjects: 287
Study 11530400 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia
Number of subjects: 57
Study 11530400 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energetic laser irradiation
Number of subjects: 57
Study 10636525 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate (2 g over 5 min followed by 16 g over 24 h)
Number of subjects: 350
Study 10636525 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate
Number of subjects: 350
Study 7924475 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous aminophylline (loading dose followed by infusion)
Number of subjects: 94
Study 7924475 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equal volume as loading dose and infusion)
Number of subjects: 94
Study 2810182 — intervention group
Group type: EXPERIMENTAL
Intervention: Polybutester (Novafil)
Number of subjects: 77
Study 2810182 — intervention group
Group type: COMPARATOR
Intervention: Polypropylene
Number of subjects: 77
Study 1107883 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 120 mg daily
Number of subjects: 21
Study 1107883 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 21
Study 31336055 — intervention group
Group type: EXPERIMENTAL
Intervention: Speechreading training
Number of subjects: 66
Study 31336055 — intervention group
Group type: COMPARATOR
Intervention: Maths training
Number of subjects: 66
Study 28466660 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous polidocanol injection (PPI)
Number of subjects: 111
Study 28466660 — intervention group
Group type: COMPARATOR
Intervention: Aspiration
Number of subjects: 111
Study 26307518 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary protocol (D)
Number of subjects: 45
Study 26307518 — intervention group
Group type: EXPERIMENTAL
Intervention: Running program (R)
Number of subjects: 45
Study 26307518 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dietary and running protocols (R&D)
Number of subjects: 45
Study 23496876 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar spinal manipulation therapy (SMT)
Number of subjects: 60
Study 23496876 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SMT)
Number of subjects: 60
Study 21518837 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous linezolid at 600 mg twice daily
Number of subjects: 8
Study 21518837 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral linezolid at 600 mg twice daily
Number of subjects: 8
Study 21518837 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrice-daily dosing of intravenous linezolid
Number of subjects: 8
Study 21518837 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrice-daily dosing of oral linezolid
Number of subjects: 8
Study 17876492 — intervention group
Group type: EXPERIMENTAL
Intervention: Ability to contract pelvic floor muscles voluntarily
Number of subjects: 343
Study 17876492 — intervention group
Group type: EXPERIMENTAL
Intervention: Involuntary contraction of pelvic floor muscles
Number of subjects: 343
Study 17876492 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with previous PFM training
Number of subjects: 343
Study 17876492 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with number of childbirths and BMI
Number of subjects: 343
Study 16585311 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction techniques during laceration repair
Number of subjects: 240
Study 16585311 — intervention group
Group type: COMPARATOR
Intervention: Control group (no distraction techniques)
Number of subjects: 240
Study 12920413 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study 12920413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11049764 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate
Number of subjects: 0
Study 11049764 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0
Study 9596908 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol (100 micrograms)
Number of subjects: 85
Study 9596908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 8122021 — intervention group
Group type: EXPERIMENTAL
Intervention: Powdered terbutaline (500 microgram) via Bricanyl Turbuhaler
Number of subjects: 30
Study 8122021 — intervention group
Group type: COMPARATOR
Intervention: Metered dose aerosol (Nebuhaler)
Number of subjects: 30
Study 3298069 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of anti-lipid A
Number of subjects: 17
Study 3298069 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 17
Study 29474007 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 102
Study 29474007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 28691254 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonics-based intervention for children with dyslexia
Number of subjects: 80
Study 28691254 — intervention group
Group type: COMPARATOR
Intervention: Control group of 93 typical readers
Number of subjects: 80
Study 26291338 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive SIJ fusion with triangular titanium implants
Number of subjects: 148
Study 26291338 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical management
Number of subjects: 148
Study 26291338 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover from nonsurgical to surgical treatment
Number of subjects: 148
Study 23073336 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 36
Study 23073336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 21493747 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT at 80% of sustained maximum inspiratory effort
Number of subjects: 40
Study 21493747 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT at 60% of sustained maximum inspiratory effort
Number of subjects: 40
Study 21493747 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT at 40% of sustained maximum inspiratory effort
Number of subjects: 40
Study 21493747 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 40
Study 18565369 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise excavation over 2 visits
Number of subjects: 0
Study 18565369 — intervention group
Group type: COMPARATOR
Intervention: Complete excavation of deep caries
Number of subjects: 0
Study 16439047 — intervention group
Group type: EXPERIMENTAL
Intervention: F (226 microg F/ml as NaF)
Number of subjects: 10
Study 16439047 — intervention group
Group type: EXPERIMENTAL
Intervention: F+X:S (xylitol:sorbitol 1:3; final concentration 1.6M; 28% of sugar alcohols)
Number of subjects: 10
Study 16439047 — intervention group
Group type: COMPARATOR
Intervention: Distilled and deionized water (negative control)
Number of subjects: 10
Study 12548082 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 80 mg/d
Number of subjects: 48
Study 12548082 — intervention group
Group type: EXPERIMENTAL
Intervention: atorvastatin 40 mg/d
Number of subjects: 48
Study 12548082 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 48
Study 10911780 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopamidol
Number of subjects: 0
Study 10911780 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol (equiosmolar solution)
Number of subjects: 0
Study 10911780 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 N Saline solution
Number of subjects: 0
Study 10911780 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study 9124806 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of extrahippocampal structural abnormalities
Number of subjects: 27
Study 9124806 — intervention group
Group type: COMPARATOR
Intervention: Absence of extrahippocampal structural abnormalities
Number of subjects: 27
Study 8411458 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin prophylaxis for 15 days following catheter removal
Number of subjects: 265
Study 8411458 — intervention group
Group type: COMPARATOR
Intervention: No antimicrobial prophylaxis
Number of subjects: 265
Study 3891203 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam disodium 2 g every 12 hours
Number of subjects: 50
Study 3891203 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin (3-5 mg/kg/day in three divided doses) and clindamycin phosphate 600 mg every six hours
Number of subjects: 50
Study 29032078 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide 10 mg every 4 weeks for 12 months
Number of subjects: 150
Study 29032078 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide 30 mg every 4 weeks for 12 months
Number of subjects: 150
Study 29032078 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide 10 mg
Number of subjects: 150
Study 29032078 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide 30 mg
Number of subjects: 150
Study 26940161 — intervention group
Group type: EXPERIMENTAL
Intervention: BBFC+TRAV
Number of subjects: 233
Study 26940161 — intervention group
Group type: COMPARATOR
Intervention: vehicle+TRAV
Number of subjects: 233
Study 24906587 — intervention group
Group type: EXPERIMENTAL
Intervention: D&G preparation (two capsules daily)
Number of subjects: 165
Study 24906587 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two capsules daily)
Number of subjects: 165
Study 23123256 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor neurological dysfunction (MND) - fine manipulative disability
Number of subjects: 341
Study 23123256 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor neurological dysfunction (MND) - coordination problems
Number of subjects: 341
Study 23123256 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordination problems in girls
Number of subjects: 341
Study 23123256 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordination problems in boys
Number of subjects: 341
Study 20864564 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise (n = 7)
Number of subjects: 24
Study 20864564 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive exercise only (n = 8)
Number of subjects: 24
Study 20864564 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group, n = 9)
Number of subjects: 24
Study 20864564 — intervention group
Group type: COMPARATOR
Intervention: Resistive vibration exercise vs. control
Number of subjects: 24
Study 20864564 — intervention group
Group type: EXPERIMENTAL
Intervention: Countermeasures (both exercise groups)
Number of subjects: 24
Study 18479954 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily administration of inhaled glucocorticosteroids
Number of subjects: 24
Study 18479954 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily administration of inhaled glucocorticosteroids
Number of subjects: 24
Study 15905346 — intervention group
Group type: EXPERIMENTAL
Intervention: Active thermoregulation
Number of subjects: 69
Study 15905346 — intervention group
Group type: COMPARATOR
Intervention: Control (no active thermoregulation)
Number of subjects: 69
Study 12683560 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy cardioversion (LEC)
Number of subjects: 48
Study 12683560 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 48
Study 10525224 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary stent implantation (STENT group)
Number of subjects: 136
Study 8712442 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 microgram/kg isoproterenol
Number of subjects: 72
Study 8712442 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.075 microgram/kg isoproterenol
Number of subjects: 72
Study 8712442 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 microgram/kg isoproterenol
Number of subjects: 72
Study 8712442 — intervention group
Group type: COMPARATOR
Intervention: 0.25 mg/kg bupivacaine and saline
Number of subjects: 72
Study 1951831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6159698 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice per week radiotherapy (2 fractions per week)
Number of subjects: 250
Study 6159698 — intervention group
Group type: COMPARATOR
Intervention: Five times per week radiotherapy (conventional regime)
Number of subjects: 250
Study 31722102 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty Development (FD) program, monthly half-day in-class sessions for 20 months
Number of subjects: 33
Study 31722102 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (nonparticipants)
Number of subjects: 33
Study 29493167 — intervention group
Group type: EXPERIMENTAL
Intervention: Distress Thermometer (DT) with a cutoff score of 3
Number of subjects: 836
Study 29493167 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis within 1–4 weeks prior to assessment
Number of subjects: 836
Study 25527737 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (RT)
Number of subjects: 105
Study 25527737 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training with Supplementation (RTS)
Number of subjects: 105
Study 25527737 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT)
Number of subjects: 105
Study 24153026 — intervention group
Group type: EXPERIMENTAL
Intervention: London Stroke Carer Training Course (LSCTC)
Number of subjects: 930
Study 24153026 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 930
Study 21338481 — intervention group
Group type: COMPARATOR
Intervention: Placebo surgery (three small incisions)
Number of subjects: 49
Study 21338481 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 49
Study 21338481 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic lavage
Number of subjects: 49
Study 19775039 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg ketamine
Number of subjects: 120
Study 19775039 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 120
Study 19775039 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 120
Study 19775039 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (0.15 mg/kg ketamine, 0.5 mg/kg ketamine, normal saline)
Number of subjects: 120
Study 16923362 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ambroxol (15 mg/kg immediately after birth, then 30 mg/kg daily for 2 days)
Number of subjects: 125
Study 16923362 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomizing ambroxol (30 mg/kg daily for 2 days)
Number of subjects: 125
Study 16923362 — intervention group
Group type: COMPARATOR
Intervention: Control (no ambroxol treatment)
Number of subjects: 125
Study 16923362 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ambroxol
Number of subjects: 125
Study 16923362 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomizing ambroxol
Number of subjects: 125
Study 16923362 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ambroxol and Atomizing ambroxol
Number of subjects: 125
Study 15016039 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (FM-SRP)
Number of subjects: 40
Study 15016039 — intervention group
Group type: COMPARATOR
Intervention: Quadrant scaling and root planing (Q-SRP)
Number of subjects: 40
Study 15016039 — intervention group
Group type: COMPARATOR
Intervention: Q-SRP (remaining untreated quadrants)
Number of subjects: 40
Study 11762561 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg eletriptan during phase 1 (menses), days 1 to 4
Number of subjects: 16
Study 11762561 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg eletriptan during phase 2 (follicular), days 6 to 10
Number of subjects: 16
Study 11762561 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg eletriptan during phase 3 (ovulatory), days 11 to 13
Number of subjects: 16
Study 11762561 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg eletriptan during phase 4 (luteal), days 21 to 24
Number of subjects: 16
Study 10322845 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiawei Dachaihu decoction (group B)
Number of subjects: 40
Study 10322845 — intervention group
Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 40
Study 7679040 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (doses of 60-65 Gy)
Number of subjects: 47
Study 7679040 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic irradiation
Number of subjects: 47
Study 7679040 — intervention group
Group type: EXPERIMENTAL
Intervention: Local irradiation
Number of subjects: 47
Study 7679040 — intervention group
Group type: EXPERIMENTAL
Intervention: Reirradiation (brachytherapy combined with hyperthermia)
Number of subjects: 47
Study 7679040 — intervention group
Group type: EXPERIMENTAL
Intervention: External irradiation for bony metastasis
Number of subjects: 47
Study 7679040 — intervention group
Group type: COMPARATOR
Intervention: Elective hemibody irradiation
Number of subjects: 47
Study 7679040 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioactive phosphorus-32 or strontium-89
Number of subjects: 47
Study 7679040 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation for spinal cord compression
Number of subjects: 47
Study 3799501 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum WIC supplementation for 5-7 months
Number of subjects: 703
Study 3799501 — intervention group
Group type: COMPARATOR
Intervention: Postpartum benefits for 0-2 months (Control)
Number of subjects: 703
Study 31854251 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-Centred Health Dialogue
Number of subjects: 785
Study 31854251 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 785
Study 31612723 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil Sublingual Tablet System (SSTS)
Number of subjects: 341
Study 28714534 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 50
Study 28714534 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable Thermoplastic Mandibular Advancement Splint (AT-MAS)
Number of subjects: 50